Seggern Christopher Von
Chief Commercial Officer, Xenon Pharmaceuticals.
Companies
- Xenon PharmaceuticalsChief Commercial Officer Aug 17, 2020 to Mar 12, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Xenon Pharmaceuticals XENE4,000 shares2$140.1K at $35.03Dec 6, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 6, 2021Bought 4,000 shares at $24.40 of Xenon Pharmaceuticals2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2